Mineralys Therapeutics
MLYSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$1.353 B
$15.28 -10.12%
Close of 6 Nov 2026
As of 6 Nov 2026, Mineralys Therapeutics (MLYS) has a market capitalization of $1.35B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$154.7M
Loss-making
Shares outstanding
88,557,097
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #125Structure TherapeuticsGPCR$1.35B
- #126Damora TherapeuticsDMRA$1.35B
- #127Mineralys TherapeuticsMLYS$1.35B
- #128AnaptysbioANAB$1.35B
- #129Eton PharmaceuticalsETON$1.35B
What if Mineralys Therapeutics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Mineralys Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.